Prevent Failure Before Completion: Doctors Inc. Launches 'Doctors Brain™', a Healthcare Business Development Support Service Starting at 50,000 Yen/Month

Doctors Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Takao Yanagawa), a company providing comprehensive support in the digital health domain—from the development of services to platform provision—has announced the launch of "Doctors Brain™," a business development support service for companies aiming to enter or expand within the medical and healthcare sector, effective June 8, 2026.

"The realization that a product is not being used in the field only after it is completed"—the biggest risk in healthcare business development lies in the "slowness" of validation. Misalignments with clinical needs discovered after development often lead to expensive rework costing tens of millions of yen, and in some cases, can lead to business withdrawal. Doctors Inc., having supported over 400 healthcare businesses, will now provide this service to organize "first-hand information from the field" obtained through interviews with physicians into specific business improvement suggestions, supporting clients from the concept stage to commercialization for as little as 50,000 yen per month.

■ Background: A Growing Market, Yet Many Entrants Fail to Reach "Practical Application"

While the domestic healthcare market continues to expand, many new entrants are withdrawing before their businesses reach practical application. The reason is not a lack of funding or technology; it is the absence of "real information" from medical front lines.

Even as the precision of business development improves, there are many cases where fatal misalignments cannot be prevented without real-world information on "what is actually happening in medical settings." In recent years, the spread of generative AI has dramatically increased the speed of market research and planning document creation. However, AI can only organize the "logic" derived from literature and data. It cannot reach the essential challenges of the medical/healthcare sector—what physicians and patients are thinking and what they perceive as problems or issues in the field.

If development progresses without noticing this lack of real information, the project risks finding out that the product is "not used in the field" after completion, leading to tens of millions of yen in rework. To solve this, Doctors Inc. has condensed its know-how from over 400 healthcare business collaborations into a new service, "Doctors Brain™," which combines "ease of contract," "real-world insights," and "translation into commercialization."

■ Three Key Features of "Doctors Brain™"

■ Commitment to Accessibility: Start Immediately for "50,000 Yen/Month"

Until now, the conventional wisdom for medical consulting was that it was "expensive, slow, and burdensome." "Doctors Brain™" overturns this. Starting at 50,000 yen per month, you can start small-scale validation without exorbitant consulting fees.

■ Beyond Validation: Integrated Support from Development, Proof of Concept, to Societal Implementation

Initial validation through "Doctors Brain™" is not the goal, but the start. Doctors Inc. provides integrated, end-to-end support throughout all phases until the verified idea reaches the actual medical field, without the need to switch companies.
(Support Examples)
・Requirement Definition & Clinical Proof of Concept (PoC): Prototype validation utilizing a network of over 75,000 affiliated medical institutions nationwide.
・Regulatory Approval & Reimbursement Strategy: Support for complex regulatory responses such as SaMD (Software as a Medical Device).
・Distribution & Societal Implementation: Deployment to medical institutions through "Doctors Hub®."

The reason for providing initial validation at the affordable price of 50,000 yen/month is simple: our true value lies in preventing rework losses and staying by the client's side until successful commercialization.

■ Future Outlook

Doctors Inc. operates multiple medical corporations and pharmacies within its group, positioning it as an entity that knows the realities of medical settings from the "inside" rather than "hearing from the outside." This firsthand experience enables support that goes beyond mere academic logic. Through this service, we will lower initial risks for companies entering the highly barrier-prone healthcare market and push for effective business development. By ensuring innovative digital health services reach clinical sites and people's daily lives as quickly as possible, we aim to contribute to the advancement of Japan's medical DX as a "platform for the societal implementation of medicine."